One of the difficulties in studying cellular interactions in the CNS is the lack of effective methods to purify specific neuronal populations of interest. We report the development of a novel purification scheme, CTB immunopanning, in which a particular CNS neuron population is selectively labeled via retrograde axonal transport of the cell-surface epitope cholera toxin beta (CTB), and then purified via immobilization with anti-CTB antibody. We have demonstrated the usefulness and versatility of this method by purifying both retinal ganglion cells and corticospinal motor neurons (CSMNs). Genomic expression analyses of purified CSMNs revealed that they express significant levels of many receptors for growth factors produced by brain endothelial cells; three of these factors, CXCL12, pleiotrophin, and IGF2 significantly enhanced purified CSMN survival, similar to previously characterized CSMN trophic factors BDNF and IGF1. In addition, endothelial cell conditioned medium significantly promoted CSMN neurite outgrowth. These findings demonstrate a useful method for the purification of several different types of CNS projection neurons, which in principle should work in many mammalian species, and provide evidence that endothelial-derived factors may represent an overlooked source of trophic support for neurons in the brain.
Introduction
A paramount question in neuroscience is to understand the cell-cell interactions that control neuronal survival, development, and function. Progress in this field of research, however, has been limited by the inability to separate most individual neuronal populations from neighboring neuronal and glial cell types. Although several groups have succeeded in purifying neuronal populations via immunopanning or fluorescence-activated cell sorting (FACS), these procedures have some significant drawbacks. Immunopanning is relatively inexpensive, gentle on cells and can produce very good yields (Barres et al., 1988) . However, immunopanning is limited by the requisite availability of an antibody that recognizes a cell surface epitope present exclusively on the cell population of interest, and few if any monoclonal antibodies have been developed that are neuron type specific. FACS is a more versatile technique, since specific populations can be labeled by genetically encoded or retrogradely transmitted fluorescent tracers, but FACS requires the availability of expensive machinery and often adversely affects the viability of fragile cells such as neurons. Here we describe a novel purification method that combines the versatility of retrograde labeling with the advantages of immunopanning. We inject targeted axonal tracts with cholera toxin beta (CTB) adsorbed to fluorescent beads to retrogradely label a neuronal population of interest. The tissue containing the labeled neuron cell bodies is then dissected and dissociated, and the neurons of interest are specifically purified via immunopanning with an anti-CTB antibody.
Our method can be used to highly purify any neuronal cell type whose projections can be selectively retrogradely labeled. We have demonstrated the efficacy of this method by purifying to more than 99% purity two populations of central nervous system (CNS) neurons, retinal ganglion cells (RGCs) and corticospinal motoneurons (CSMNs), from early postnatal rat pups. CSMNs residing in cortical layer V of the brain project their axons to the spinal cord where they connect with spinal motor neurons (SMNs) located in the ventral horn of the spinal cord. CSMNs are in charge of controlling voluntary movements, and their importance becomes obvious in situations where this network breaks down. For instance both CSMNs and SMNs progressively degenerate in amyotiophic lateral sclerosis (ALS) (Pasinelli and Brown, 2006) . In addition, damage to CSMN axons and their subsequent failure to regenerate underlie the loss of motor function in severe spinal cord injuries (Schwab, 2002) .
Recently, there has been great progress on the anatomical, morphological and genetic characterization of developing CSMNs. However, most previous studies examining the growth and survival requirements of CSMNs have been performed using in vivo axotomy studies, in which it is difficult to separate direct versus indirect effects on the CSMNs (Giehl et al., 2001; Giehl et al., 1998; Hammond et al., 1999; Lu et al., 2001; Schutte et al., 2000; Tuszynski et al., 2003) . More recently, two groups have succeeded in purifying CSMNs via FACS (Arlotta et al., 2005; Junger and Junger, 1998; Ozdinler and Macklis, 2006) , and have generated the first direct data on CSMN survival requirements. Our method produces significantly higher yields than FACS purification, and agrees with many previous studies in finding that brain derived neurotrophic factor (BDNF) and insulin-like growth factor 1 (IGF1) are important survival factors for early postnatal CSMNs (Giehl et al., 2001; Giehl et al., 1998; Hammond et al., 1999; Lu et al., 2001; Ozdinler and Macklis, 2006; Schutte et al., 2000) . We have also analyzed purified CSMN gene expression by gene chip hybridization, which has revealed that CSMNs express numerous receptors for growth factors secreted by vascular cells in the brain (endothelial cells and pericytes). Upon testing these growth factors, we discovered that insulinlike growth factor 2 (IGF2), chemokine (C-X-C motif) ligand 12 (CXCL12, a.k.a. SDF1α), and pleiotrophin (PTN), which are all highly expressed by vascular cells in the developing brain, are equally as potent as BDNF or IGF1 at supporting CSMN survival. In addition, we found that endothelial-conditioned medium significantly promotes CSMN neurite outgrowth. These data suggest a hitherto unsuspected role of brain vascular cells in supporting CNS neuron survival.
Adsorption of cholera toxin beta to Lumafluor Retrobeads IX
Green Lumafluor Retrobeads IX (20 μl; Lumafluor Inc, Naples, FL) were combined with cholera toxin beta subunit (CTB) (100 μl of 1 mg/ml solution; List Biological Laboratories, Campbell, CA). The solution was protected from light and incubated overnight at 4°C while gently shaking to facilitate adsorption of CTB to the beads. Microspheres were pelleted by ultracentrifugation at 4°C for 45 minutes at 60,000 rpm in a benchtop ultracentrifuge (Beckman optima TLX; TLA 120.2 rotor). Subsequently, 100 μl of the supernatant was removed and the pellet was resuspended in the remaining 20 μl, then stored at 4°C until use.
Retrograde labeling of RGCs
Early postnatal (postnatal day 2-6: P2-P6) Sprague Dawley rats (Charles River, Wilmington, MA) were anesthetized using isoflurane. The skull was exposed on the dorsal surface by making a small longitudinal incision in the skin midline. Injections were performed without the aid of a stereotactic device; in early postnatal rats the needle could be accurately positioned 2 mm lateral to the sagital sinus just anterior to its intersection with the transverse sinus, at a depth of 4 mm. At these coordinates, the injection site was at the intersection of the dorsal midbrain and diencephalon (Potts et al., 1982) . The skull was gently punctured with a 30-gauge needle, allowing easy penetration of the injection needle to the required depth, after which 1 μl of CTB-adsorbed green Lumafluor Retrobeads IX was injected into the superior collicular brachium bilaterally. Injections were performed over a time span of approximately one minute with a 5-μl Hamilton syringe. After the injection, the wound was closed with surgical glue. After recovery, the animals were returned to their mother for 2-3 days to allow complete retrograde transport of the injected tracer.
Retrograde labeling of CSMNs
Age P1-P8 Sprague Dawley rats were anesthetized using isoflurane. An incision was made in the skin at the back of the skull, and muscle tissue and the atlantal-occipito membrane were reflected, exposing the underlying dura. Next, the injection needle was lowered in between the foramen magnum and the atlas into the pyramidal decussation at the junction of the medulla and cervical spinal cord. Subsequently, 1 μl of CTB-adsorbed green Lumafluor Retrobeads IX was injected over a time span of approximately one minute with a 5-μl Hamilton syringe, using a 32-gauge needle. After the injection, the needle was slowly retracted, muscle tissue was sutured and the skin was closed using surgical glue. After recovery, the animals were returned to their mother for 2-3 days to allow complete retrograde transport of the injected tracer.
RGC purification and culture
RGCs from P2-P6 Sprague Dawley rats that had been labeled via retrograde tracing with CTBadsorbed Retrobeads were purified as previously described with some modifications (Barres et al., 1988) . Briefly, dissected retinas were analyzed under a fluorescent inverted microscope, and labeled retinas were selected for CTB panning. Unlabeled retinas were used in parallel for established immunopanning using the Thy1.1 cell surface epitope expressed by RGCs. Retinas were enzymatically dissociated in papain (Worthington, Lakewood, NJ) at 37°C for 30 minutes then gently triturated to create a single-cell suspension. The cell suspension was first incubated sequentially on two Griffonia (Bandeiraea) Simplicifolia Lectin I (BSLI; Vector Laboratories, Burlingame, CA) coated Petri dishes for 30 minutes each to remove most microglia and macrophages from the cell suspension. Subsequently, in the case of CTB immunopanning, the cells were incubated in a closed tube at 37°C for 1 hour to allow recovery of the CTB epitope to the cell surface, after which the cells were poured onto a plate coated first with anti-mouse IgG Fc γ fragment specific antibody (Jackson Immunoresearch Labs Inc, West Grove, PA) overnight, then coated with 140 μg mouse monoclonal anti-CTB (mouse monoclonal IgG1, clone 3D11; Biodesign International, Saco, Maine) and allowed to bind for 1 hour at room temperature. In the case of Thy1 immunopanning, the cell suspension was incubated on a T11D7 (monoclonal supernatant IgM antibody against mouse Thy1.1; American Type Culture Collection, Manassas, VA) coated dish under the same conditions. After extensive rinsing, cells that remained attached to the plate were released using trypsin (Sigma-Aldrich, St. Louis, MO) and plated on glass coverslips (Carolina Science and Math, Burlington, NC) coated with poly-D-lysine (pDL, 70 kDa; Sigma) and Cultrex mouse laminin (Trevigen, Gaithersburg, MD) in serum-free media as previously described (Meyer-Franke et al., 1995) . For in vitro synaptogenesis assays, previously published protocols were followed (Christopherson et al., 2005; Ullian et al., 2001) .
CSMN purification and culture
After retrograde labeling of CSMNs with CTB, animals were sacrificed and the cortices were isolated by removal of the midbrain, hippocampi, olfactory bulbs and meninges. Cortices were examined under an inverted fluorescence microscope and only labeled cortices were used (e.g. Fig. 2B ). Cortices were enzymatically dissociated with papain (800 units) and L-cysteine (3.2 mg, for papain activation; Sigma) for 1 hour at 34°C in a sucrose buffer containing sucrose (152 mM), NaHCO 3 (26 mM), NaH 2 PO 4 (0.9 mM), CaCl 2 (1.8 mM), MgCl 2 (0.8 mM), KCl (5.4 mM), glucose (25 mM), phenol red (5 μg/ml), APV (50 μM), kynurenic acid (800 μM), glutathione reduced (1 μg/ml), catalase (2.5 μg/ml), superoxide dismutase (2.5 μg/ml), D.L.-α-tocopherol (1 μg/ml), D.L.-α-tocopherol acetate (1 μg/ml) (all from Sigma), HEPES (10 mM; USB Corporation, Cleveland, OH), sodium pyruvate (0.23 mM; Invitrogen), and DNase I (5000 units; Worthington). Sucrose buffer was equilibrated in 10% CO 2 before use, and during digestion was maintained under a stream of 95%O 2 :5%CO 2 . Cortices were then mechanically dissociated first with a 25 ml pipette, then with a fire-polished glass pipette in the sucrose buffer plus 1.5 mg/ml ovomucoid trypsin inhibitor (Roche, Indianapolis, IN) to inhibit the papain. Dissociated cells were spun through sucrose buffer with 5 mg/ml ovomucoid trypsin inhibitor for 15′ at 220 rcf, resuspended in sucrose buffer and spun through a cushion of 4% BSA (Sigma) for 10′ at 220 rcf. Cells were resuspended in sucrose buffer and allowed to recover for 1 hour at 37°C in a 10% CO 2 incubator. During recovery, cells were gradually switched to a nonsucrose buffer in a stepwise fashion by adding saline buffer every 10′. Saline buffer was as described above, but lacking sucrose, NaHCO 3 and DNase I, and containing 102 mM NaCl (Fisher Scientific Co, Santa Clara, CA). Cells were then passed through a Nitex filter (20 μm pore size; Sefar America, Kansas City, MO) and poured sequentially onto two Petri dishes coated with 2.5 μg/ml BSLI (Vector Laboratories). Cells were incubated for 20′ on each dish in 5% CO 2 at room temperature. Microglia, endothelial cells and red blood cells adhered to the BSLI plates. The supernatant was then poured onto an anti-CTB coated dish (140 μg for P3, 210 μg for P7). This dish was incubated for 45′ at room temperature in 5% CO 2 . After extensive rinsing, adhered cells were removed by incubation in 0.25% trypsin (Sigma) for 6′ at 37°C. Trypsin was inhibited by addition of 30% heat-inactivated fetal calf serum (Invitrogen), and cells were mechanically dislodged by pipetting and pelleted at 220 rcf for 10′. Cells were resuspended in growth medium and plated at a density of 35 cells/sq. mm onto either 96-well tissue culture plates or onto 12 mm glass coverslips in 24-well plates. In either case the substrate was coated with 10 μg/ml pDL and 2 μg/ml Cultrex mouse laminin I overnight. Plates were spun down at 150 rcf for 2′ to facilitate adhesion of the CSMNs to the substrate.
CSMNs were cultured in growth medium consisting of 50% Dulbecco's Modified Eagle's Medium (DMEM) and 50% Neurobasal containing sodium pyruvate (1 mM), L-glutamine (2 mM), penicillin (100 units), streptomycin (100 μg/ml) (all Invitrogen), human transferrin (100 μg/ml), progesterone (60 ng/ml), putrescine (16 μg/ml), sodium selenite (40 ng/ml), thyroxine (40 ng/ml), tri-idothyronine (30 ng/ml), glucose (35 mM), BSA (0.34%) (all Sigma) and B27 supplement (Invitrogen) or SCAVEGR antioxidants (BrainBits, Springfield, IL). In some experiments CPTcAMP (125 μM; Sigma) was also present. Added growth factors included BDNF (100 ng/ml; gift from Regeneron), IGF1, IGF2 (both at 50 ng/ml; Peprotech), CXCL12, and PTN (both at 100 ng/ml; Peprotech). In some experiments, bovine insulin (Sigma) was substituted for IGF1 at 5 μg / ml. Cells were maintained in 37°C 10% CO 2 incubators and fed with 50% replacement fresh media every 3 DIV.
Endothelial cell purification and culture
Endothelial cells were purified from the cerebral cortex of p20 of rats through modification of methods described elsewhere (Cahoy et al., 2008; Mi et al., 2001) . Briefly, the cerebral cortices of rats were dissected out of the skull and the meninges were removed with forceps. Tissue was diced using a scalpel blade, and then dissociated with an enzymatic solution of papain (5 U/ml, Worthington-3126) containing L-cysteine (0.4mg/ml, Sigma C 7477) and DNase (125 U/ml, Worthington LS002007) for 20 minutes at 35°C. The tissue was then triturated with 5 ml pipette tips in a solution containing ovomucoid (2mg/ml, Roche), DNase (125U/ml) and BSA (1mg/ml, Sigma) to generate a cell suspension which was recovered by centrifugation. Endothelial cells were purified by incubation of the cell suspension in a series of mouse anti-CD45 (Serotec, Raleigh, NC) coated dishes to deplete microglia, and an anti-PDGFRβ (R&D systems, Minneapolis, MN) coated dish to deplete pericytes, followed by selection on an anti-CD31 (Fitzgerald, Concord, MA) coated dish. The endothelial cells were recovered by trypsinization, and plated on CIV (BD Biosciences, San Jose, CA) coated coverslips. Purity was measured 2 hours after purification by staining with claudin 5 (Invitrogen) and deemed greater than 98% pure claudin 5+ endothelial cells. Vascular cells were grown in a basal medium containing insulin, pyruvate, glutamine, SATO, N-acetyl cysteine, forskolin and antibiotics, with bFGF and 0.5% FCS for two weeks. Puromycin (1μg/ml) was added for the first 3 days to non-endothelial cell contaminants.
After two weeks in culture to allow the endothelial cells to grow to confluency, the cells were rinsed and basal serum-free CSMN medium containing CPT-cAMP was added to the wells. After 2-3 days the conditioned medium (ECM) was collected, transferred to a Vivaspin 5kD molecular weight cutoff filter (Vivascience, Littleton, MA), and concentrated by centrifugation at 4°C, 2000 rcf until 1/10 original volume. The 10x ECM was then immediately added to CSMNs at 1:10 (e.g. 10 μl 10x ECM + 100 μl CSMN medium).
Viability and morphology assays
Viability of cultured CSMNs and RGCs was assessed using LIVE/DEAD Viability/ Cytotoxicity Kit (Invitrogen) following manufacturer instructions, in which live cells are labeled by their ability to enzymatically convert calcein AM to fluorescent calcein, and dead cell nuclei are labeled with ethidium homodimer-1. Cells were visualized on a Nikon Eclipse TS100 inverted fluorescence microscope and pictures taken with a SPOT-RT digital camera (Diagnostic Instruments, Sterling Heights, MI) using SPOT software (Diagnostic Instruments). Images were further analyzed for process extension and branching with Metamorph software (Molecular Devices, Sunnyvale, CA). For morphology assays, images of > 20 live cells / condition were analyzed. For survival assays, at least 200 cells per condition were counted and viability was calculated as the percentage of live cells over total cells.
Cryosectioning and immunohistochemistry
At specified time points, rat pups were lethally anesthetized with ketamine/xylazine and then fixed by transcardial perfusion with 4% paraformaldehyde using a perfusion pump. After fixation, the brains or retinas were removed and post-fixed by immersion in 4% PFA for 2 hours at 4°C. Tissue was then equilibrated in 30% sucrose in PBS overnight at 4°C, mounted in a sucrose:OCT solution consisting of 2 parts 30% sucrose: 1 part Tissue-Tek OCT Compound (Sakura Finetek, Torrance, CA), frozen using dry ice or liquid nitrogen and stored at -80°C until cryosectioning. 14-μm-thick sections were generated on a Leica CM3050 cryostat and mounted on slides. Immunostained slides were blocked for 30 minutes at room temperature in 50% normal goat serum in antibody buffer containing NaCl (150 mM), Tris Base (50 mM) (both Fisher Scientific), L-Lysine (100 mM), 1% BSA (both Sigma), 0.04% sodium azide, and 0.4% Triton X-100 to permeabilize cell membranes. Sections were then incubated overnight at 4°C in antibody buffer containing 1:500 anti-CTIP2 antibody (ab18465; Abcam, Cambridge, MA). Finally, slides were incubated for 1 hour at room temperature in the dark in antibody buffer containing 1:500 Alexa Fluor 594 goat anti-rat secondary antibody (A-11007; Invitrogen). Slides were mounted using a PBS-glycerol based mount (VectaShield Mounting Medium with DAPI; Vector Laboratories). Sections were examined and imaged on a Nikon Eclipse E800 fluorescence microscope as described above.
Immunocytochemistry
Cells cultured on glass coverslips were immunostained by fixing for 10 minutes in 4% PFA, then blocking for 30 minutes in 50% goat serum in antibody buffer with Triton X-100 as described above. Coverslips were incubated overnight at 4°C in antibody buffer containing 1:500 anti-MAP2 antibody (M1406; Sigma) and 1:500 anti-CTIP2 antibody. Finally, coverslips were incubated for 2 hours at room temperature in the dark with antibody buffer containing 1:1000 Alexa Fluor 488 goat anti-mouse secondary antibody (A-11001; Invitrogen) and 1:1000 Alexa Fluor 594 goat anti-rat secondary antibody (A-11007; Invitrogen), then mounted on slides using Vectashield+DAPI (Vector Laboratories) and imaged as described above.
RNA purification, amplification and gene chip hybridization
Total RNA was isolated from acutely purified cells with the RNeasy Micro kit (Qiagen, Valencia, CA), using Qiashredder columns for cell lysis, and inserting Qiagen on-column DNase steps to remove any contaminating genomic DNA. CSMNs from P3 and P7 rat pups were purified as described above. For the whole brain sample, one litter of P3 mice were injected and subsequently subjected to the same purification protocol as for CSMNs, but following the BSL-plate panning steps, the entire non-adherent cell suspension was collected. The vascular cell samples were prepared as described elsewhere (R. Daneman et al., submitted). Briefly, vascular cells were FACS sorted from transgenic homozygous Tie2GFP mice (strain 003658), obtained from Jackson Laboratories (Bar Harbor, ME), in which all endothelial cells express GFP. For brain samples (adult and first postnatal week), the cerebral cortex was dissected away from the forebrain, then the meninges were peeled off with fine forceps. For the adult liver, the periphery of each lobe was dissected and utilized as to avoid the hepatic portal vein, thus the tissue utilized had vasculature consisting primarily of sinusoidal capillaries. For the adult lung, whole lung lobes were utilized. Each tissue was diced with a scalpel, and enzymatically dissociated as described previously to yield a total cell suspension that was subsequently recovered by centrifugation. Cell suspensions were re-suspended in FACS buffer (DPBS, 0.02%BSA with propidium iodide), and endothelial cells (and tightly associated pericytes) were FACS purified based on GFP fluorescence utilizing a FACS Vantage SE sorter (Becton Dickinson) and CellQuest software.
For each sample, ∼30 ng of total RNA was amplified and labeled by Affymetrix (Santa Clara, CA) Two-Step Labeling Kit protocols. Fragmented, biotin-labeled cRNA was then applied to Affymetrix Rat Genome 230 2.0 arrays (CSMN and whole brain samples) or Mouse Genome 430 2.0 arrays (vascular samples) at the Stanford Protein and Nucleic Acid Biotechnology Facility according to Affymetrix protocols. Expression data was generated from chip scans using Affymetrix GeneChip Operating Software (GCOS).
Results

Development of a new method for purification of specific populations of CNS neurons
Cholera toxin is the pathologically active agent secreted by the bacterium Vibrio cholerae, and is composed of two subunits, A and B. The A subunit is the toxic part, while the pentameric B subunit is non-toxic and is required for the binding of cholera toxin to its cell-surface receptor, ganglioside GM1 (Spangler, 1992) , a ubiquitous membrane component expressed in both neurons and glia in the adult CNS (Cuatrecasas, 1973) . The cholera toxin B subunit (CTB) is internalized by cell processes via its binding to GM1 (Chinnapen et al., 2007) , then retrogradely transported back to the cell body, where CTB has been shown to recycle back to the cell surface (Nickel, 2005; Pelkmans and Zerial, 2005) . CTB is commonly used as a retrograde tracer due to its high sensitivity, rapid axonal transport and stability in neurons (Oudega et al., 1994) . The properties of CTB suggested that we could use retrograde CTB labeling to insert a cell-surface marker that would be specific for only that labeled cell population. We wanted to investigate whether the presence of CTB at the cell surface could be used to purify populations of neurons via immunopanning. To do this, we modified an immunopanning technique first developed for the purification of RGCs (Barres et al., 1988) .
In our initial experiments we used Alexa488-or Alexa594-conjugated CTB molecules to retrogradely label RGCs, and subsequently purified the cells by incubation with a monoclonal antibody to CTB. Although we were able to highly purify the RGCs from a retinal cell suspension, our yields were low. This was likely due to the enzymatic digestion of cell-surface CTB by papain during the dissociation step, leaving only a minor amount of non-proteolytically cleaved CTB available for immunopanning. To increase the amount of CTB recycled from intracellular stores back to the cell surface after papain treatment, we retrogradely labeled RGCs with CTB-coated fluorescent Retrobeads IX. It has been shown previously that these beads are non-toxic, and that they gradually release various growth factors adsorbed to their surface over several days (Katz et al., 1984; Riddle et al., 1997; Riddle et al., 1995) . We therefore reasoned that injection of CTB-coated Retrobeads would generate retrogradely labeled cells with increased intracellular stores of CTB, which would be protected from proteolytic papain digestion during tissue dissociation. This adjustment greatly improved our yields (Fig. 1A) .
CTB panning of RGCs is comparable to established protocols for RGC isolation by panning
To address the question of whether CTB can be used to immunopurify retrogradely labeled neuronal populations, we first investigated this possibility in RGC neurons, which we routinely purify via immunopanning using antibodies directed against the RGC-specific surface epitope Thy1.1 (Barres et al., 1988) . RGCs were retrogradely labeled by injecting CTB adsorbed to fluorescent Retrobeads into the superior colliculi (Fig. 1B) . Numerous RGCs were fluorescently labeled 48 hours after injection of the tracer (Fig. 1C) . At that time point, fluorescently labeled retinas were dissected and a single cell suspension was generated. Following dissociation, the cell suspension was applied to Bandeiraea (Griffonia) simplicifolia lectin I (BSLI) coated panning dishes to remove microglial cells before incubation of the cell suspension on the final anti-CTB coated panning dish. This was necessary because microglial cells could potentially bind non-specifically to the final panning dish via their expressed Fc receptors (Reichert and Rotshenker, 1996) . Also, microglia have high levels of GM1 (Nedelkoska and Benjamins, 1998) , and therefore could pick up CTB released by lysed cells, which would enhance their binding to the final panning dish. Microglia bind with high affinity to BSLI (Kaur and Ling, 1991; Kaur et al., 1990; Streit and Kreutzberg, 1987) , and therefore can be efficiently removed from the cell suspension before the final panning dish, eliminating this potential problem.
Following removal of microglia from the cell suspension, retrogradely labeled RGCs were selected by their binding to a CTB-specific antibody coated panning plate. Purified RGCs survived and extended neurites under standard RGC growth conditions (Fig. 1D-E) . The cell suspension that did not adhere to the anti-CTB panning dish was transferred to a panning dish coated with anti-Thy1.1 antibody (T11D7 clone). By comparing the number of cells attached to the anti-CTB dish to those attached to the T11D7 dish, we determined that the anti-CTB panning dish was able to purify approximately 30% of all RGCs that could possibly be panned from retinas isolated from rat pups at postnatal day 6 (P6) ( Table 1 ). This ratio is reduced at later developmental timepoints (22.5% at P8 and 15.1% at P10). These data demonstrate that CTB-labeled RGC neurons can be efficiently purified by immunopanning using a CTB specific antibody.
There have been several reports describing the effect of CTB on neurite outgrowth and responses to neuronal growth factors (Doherty and Walsh, 1987; Masco et al., 1991; Mutoh et al., 1993; Wu et al., 1994) . Therefore, we wanted to address whether CTB labeling of RGC neurons interferes with the cellular functions of RGCs. We first compared the response to growth factors of anti-CTB-and T11D7-panned cells. Both groups of RGCs responded similarly to RGC survival factors CNTF and BDNF, and also our previously characterized "full" RGC growth medium containing BDNF, CNTF, insulin and the cAMP elevating compound forskolin (Fig. 1F ). We were also unable to detect significant differences between the abilities of anti-CTB-and T11D7-panned neurons to extend neurites and generate synapses ( Fig. S1-2) . Cumulatively, these data demonstrate that retrograde labeling of neurons with CTB bound to Retrobeads enables the targeted neurons to be highly purified via immunopanning without adversely affecting their viability or other normal cellular processes.
Early postnatal rat CSMNs can be purified to 99% purity with CTB panning
We next sought to use this method to purify CSMNs from neonatal rat pups. We injected CTB conjugated to fluorescent Retrobeads into the pyramidal decussation of the spinal cord of rat pups at P1 (Fig. 2A) . After waiting two days for the label to be retrogradely transported to the cortex, the pups were sacrificed, the cortex was dissected and then gently dissociated. Only cortices that were detectably labeled were included in the dissociations (Fig. 2B-C) . To improve our yield of CSMN neurons, we modified our dissociation buffers by replacing sodium chloride with sucrose. Dissection and dissociation in iso-osmolar sucrose solution has been found to improve the health of motoneurons (Aghajanian and Rasmussen, 1989) . It is thought that passive chloride entry during dissociation has an acute neurotoxic effect, leading to cell swelling and lysis of neurons; by eliminating sodium chloride in the buffer, this was prevented. This simple modification increased our yields and improved the health of acutely purified neurons to more than 90% viability after initial dissociation (data not shown).
Once purified, dissociated cells were plated at a density of 35 cells / sq. mm and cultured for 1-9 days in vitro (DIV). Purifications performed at P3 typically gave a final yield of 9510 ±2590 S.D. CSMNs / brain (n=19). Yields were similar for purifications performed at P4-5 (data not shown), but dropped off sharply for older rats. Purifications performed at P7 produced only 3000 ±600 S.D. CSMNs / brain (n=7), and purifications attempted at P10 yielded very few neurons (data not shown).
To verify that purified cells were CSMNs, we first immunostained cortical slices with COUP-TF-interacting protein 2 (CTIP2), a transcription factor that has been found to be specifically expressed by layer V cortical cells (Arlotta et al., 2005; Molyneaux et al., 2007) (Fig. 2D-E) . Anti-CTIP2 was localized exclusively to the nuclei of layer V cells. Green fluorescent microbeads were seen in the cell bodies and neurites of layer V cells, but not elsewhere, demonstrating that our technique specifically labels layer V neurons. All fluorescently labeled cells co-stained with CTIP2, although not every CTIP2 positive cell was labeled with microbeads. Second, we verified that our CTP-immunopanned cell cultures were pure CSMNs by co-staining the cultured cells with anti-CTIP2 and a neuronal marker, anti-MAP2 (Fig. 2F) . We observed a 100% correlation between anti-MAP2 and anti-CTIP2 cell staining, indicating that all isolated neurons were CSMNs. Cultures were also stained with DAPI nuclear stain; almost all DAPI nuclei co-stained with CTIP2 (99.1% ±1.1% S.D.). Therefore isolated cultures are 99.1% pure CSMNs.
Genomic expression analysis to confirm purified CSMN identity
We next compared the pattern of gene expression in our purified P3 CSMNs to gene expression in the whole dissociated brain by Affymetrix Rat Genome 230 2.0 array hybridization (Table  S1 ). We found that our population of purified CSMNs expressed several standard neuronal markers, as expected ( Fig. 3A and Table S2 ). Furthermore, we observed that, relative to the whole brain sample, our purified CSMNs expressed minimal levels of all the astrocyte, oligodendrocyte / oligodendrocyte precursor cell, and vascular cell markers we analyzed. These data confirmed that our method had successfully isolated a highly pure population of neurons. Similar results were observed for CSMNs purified from P7 rats, although the population appeared to be slightly less pure than the P3 preparation (Table S1 ).
To analyze the identity of the neurons we had purified, we determined the expression of genes previously reported to be specific for CSMNs (crim1), genes reported to be specific for layer V subcerebral projection neurons, which includes CSMNs (bcl11b, fezf2, ldb2, S100a10 and pcp4) and genes reported to be enriched in layer V (contactin 6 and cadherin 13) (Arlotta et al., 2005; Molyneaux et al., 2007) . Most were highly expressed relative to average gene expression levels in our purified population (Table S2 ). When we compared the expression levels in our purified cells to the expression levels found in whole cortex, these CSMN-specific genes were generally enriched in our purified cells (Fig. 3B and Table S2 ), providing further evidence that our protocol successfully purified CSMNs from total neurons.
In vitro survival of purified CSMNs is enhanced by the presence of antioxidants and cAMP
We cultured purified CSMNs in defined, serum-free media. In initial experiments we supplemented the media with B27, a chemically defined serum replacement mixture allowing high neuronal survival and reduced glial growth (Brewer et al., 1993) . To determine the contribution of B27 to the short-term survival of CSMNs, we also excluded B27 from the growth medium, added B27 without antioxidants, or added antioxidants only (SCAVEGR supplement, BrainBits, Springfield, IL). Short-term survival of CSMNs was almost zero in the absence of B27 or in the presence of B27 without antioxidants, whereas antioxidants (SCAVEGR) alone had the same beneficial effect on short-term survival as B27 (data not shown). Therefore, in all of the subsequent experiments described below, we supplemented our growth medium with SCAVEGR instead of B27.
In addition, we tested whether increasing intracellular levels of cAMP could enhance CSMN viability. CPTcAMP was added to mimic the effects of electrical excitation by raising cAMP levels, which has previously been shown to be crucial to enhancing CNS neuron responsiveness to trophic factors Meyer-Franke et al., 1995; Meyer-Franke et al., 1998) . Addition of CPT-cAMP alone to purified cultures of CSMNs was sufficient to significantly enhance survival (Fig. 4A) , from 15% to 24% over 5 DIV (p < 0.0001, two-tailed Student's T-test). CPT-cAMP was therefore included in all of our CSMN survival assays when testing added trophic factors or conditioned medium.
In vitro survival of purified CSMNs is enhanced by the presence of BDNF and IGF1, but these factors are not sufficient to support long-term survival
To investigate the trophic factor requirements of CSMNs, we began by determining the effectiveness of the previously characterized CSMN survival factors BDNF and IGF1 (Giehl et al., 2001; Giehl et al., 1998; Hammond et al., 1999; Lu et al., 2001; Ozdinler and Macklis, 2006; Schutte et al., 2000) at promoting purified CSMN viability. We found that both factors could reproducibly increase CSMN 5 DIV survival by a small but significant amount ( Fig. 4A; 1.25-fold increase from 24% to 30%, p < 0.001 ANOVA post-hoc Student-Newman-Keuls test). In addition, we observed a similar increase in neuronal process outgrowth and complexity (branching) in cells cultured in the presence of BDNF (Fig. 5C ) or IGF1 (data not shown) relative to surviving cells in CPT-cAMP only controls (Fig. 5B,G,H) . These data confirm that the trophic responsiveness of the cells we have isolated via our novel CTB immunopanning method conform to the previously reported behavior for purified CSMNs.
To further examine the survival requirements of the purified CSMNs, we performed a more detailed analysis of the ability of IGF1 and BDNF to promote viability of CSMNs over time in vitro. In these experiments, 5 μg / ml insulin, which stimulates IGF1 receptors at high concentrations (Schumacher et al., 1993) , was substituted for IGF1. We consistently found that the survival of purified P3 CSMNs steadily declined over time in either medium containing only insulin, or insulin + BDNF (Fig. 4B) . Similar results were obtained when we purified CSMNs from P7 rats, although their survival appeared to decline more rapidly than the CSMNs obtained from younger rats (Fig. 4C ). These data indicate that the previously characterized CSMN growth factors IGF1 and BDNF can enhance the viability of our CTB-immunopurified CSMNs, but that they are insufficient to fully support the long-term survival of these cells.
Genomic expression analysis shows that P3 and P7 CSMNs express many receptors for growth factors secreted by brain endothelial cells
To identify potential further, possibly previously unrecognized sources of trophic support for CSMNs, we decided to analyze the gene chip data we had generated to determine if we could identify additional growth factor receptors that are robustly expressed by CSMNs. Knowing that BDNF and IGF1 could enhance CSMN viability, we began by determining the expression levels of other trophic factor receptors belonging to these families. We found that the BDNF receptor, NTRK2, was apparently the most robustly expressed member of the TRK family of receptors (Table S1 ). When we compared the expression levels of the IGF receptors, however, we found that IGF2R was expressed at least the same level as IGF1R. We therefore decided to examine the ability of IGF2 to support CSMN survival further.
To identify additional potentially uncharacterized CSMN trophic factor receptors, we analyzed the list of genes that were expressed at a level at least 3-fold higher than the average level across the entire gene array (731 arbitrary units). We found that the receptors for known growth factors such as CXCL12 (SDF1α), PTN, transforming growth factor β (TGFβ), and semaphorin 7a (Sema7a) were highly expressed, typically at levels of 3000 (Table 2 ). In comparison, the expression level of the BDNF receptor, Ntrk2, in purified CSMNs was 1896, and the receptor for IGF1 was expressed at a level of only 211, both lower than the levels for the several growth factor receptors described above.
To confirm the layer V expression of many of the receptors listed in Table 2 , we examined the in situ hybridization data for these genes in the Allen Brain Atlas, and found that several of these receptors did appear to be expressed in layer V (Fig. S3) . Interestingly, we noticed that most of the growth factor ligands of the receptors listed above are highly expressed by vascular cells in the brain as shown by gene chip analysis of purified brain endothelial cells and pericytes (R. Daneman et al., submitted) ( Table 2 ), and that several of these factors appeared to be most highly produced by the vascular cells of the CNS relative to non-neural vasculature (Table S3) . This raised the intriguing possibility that vascular cells may be providing trophic support to CSMNs in the CNS.
Brain endothelial cells help support the survival and growth of purified CSMNs
To test whether brain vascular cells could support CSMN survival, we began by purifying and culturing brain endothelial cells (ECs) from postnatal rats. Via immunopanning for CD31, we were able to obtain cultures of brain ECs that were greater than 98.5% pure, as assayed by claudin 5-positive immunoreactivity (data not shown). These cells were maintained in 0.5% serum-containing media for 2-3 weeks in vitro until nearly confluent, at which point the cells were thoroughly rinsed to remove traces of serum, and then incubated for 2-3 DIV in the same basal serum-free medium formulation (+CPT-cAMP, no growth factors) used for CSMN cultures. The serum-free EC conditioned medium (ECM) was then collected and concentrated 10-fold by centrifugation through a 5kD MWCO filter, which should retain any large protein trophic factors secreted into the medium by ECs. Concentrated 10x ECM was immediately added at a 1:10 ratio to fresh cultures of pure CSMNs that had been plated in medium containing only CPT-cAMP with no additional growth factors.
We found that the addition of ECM significantly increased the viability of pure cultured CSMNs (Fig. 4A ). In addition, we observed that the surviving CSMNs cultured in the presence of ECM in general looked much healthier, extending a greater number of more highly-branched processes than CSMNs surviving in CPT-cAMP only medium, or even CSMNs cultured with BDNF (Fig. 5B,C,F) . These data indicate that brain ECs represent an underappreciated, potentially potent source of trophic support for CSMNs.
Factors produced by brain endothelial cells, IGF2, CXCL12 and PTN, have comparable survival activity to BDNF and IGF1 for cultured CSMNs
After finding that brain ECs could support CSMN survival, we next wanted to determine whether individual growth factors that are highly expressed by ECs could similarly enhance CSMN viability. To determine whether these EC-secreted proteins could support CSMN survival, we cultured purified CSMNs for 5 DIV in the presence of IGF2, CXCL12, or PTN. We found that all three were individually able to promote CSMN survival similar to the levels observed for BDNF and IGF1 (Fig. 4A) . We also assessed the morphology of the surviving cells, and found that IGF2 (Fig. 5D) , CXCL12, and PTN (data not shown) could all increase CSMN total process outgrowth and branching to a similar or even slightly greater degree than BDNF (Fig. 5C ,G,H) or IGF1 (data not shown). When we combined IGF2, CXCL12, PTN and BDNF all together, we observed only a slight enhancement of CSMN survival relative to single growth factors (Fig. 4A) . We also noted that adding IGF1 to this mix did not further increase CSMN viability (data not shown). Interestingly, while a cocktail of CSMN trophic factors did not greatly increase the long-term survival of the purified CSMNs, exposure to multiple ECM-derived trophic factors + BDNF did enhance the process extension and branching of the surviving cells over the levels observed for single trophic factors (Fig. 5C-E,G,H) . Consistent with the hypothesis that brain ECs support CSMN viability by secreting IGF2, CXCL12, and PTN, we found that addition of these factors, either alone or in combination with BDNF and IGF1, to 10x ECM did not further enhance the ability of ECM to support CSMN survival (Fig. 4A) . We also observed no significant difference between the morphology of CSMNs cultured in the presence of ECM (Fig. 5F ), a cocktail IGF2, CXCL12, PTN, and BDNF (Fig. 5E ), or ECM + the trophic factor cocktail (data not shown). Cumulatively, these data indicate that brain EC-secreted IGF2, CXCL12 and PTN are likely an important, previously unidentified source of trophic support for CSMNs.
Discussion
Development of a novel method for purification of CNS projection neurons
CTB immunopanning is a novel neuron purification method that allows projection neurons to be retrogradely labeled with CTB, and then purified by immunopanning with an anti-CTB antibody. We have demonstrated the utility of this method for purifying two different populations of CNS neurons, RGCs and CSMNs. Thanks to the ubiquitous expression of GM1 by central neurons (Cuatrecasas, 1973) , this method should be broadly applicable, allowing for the purification of any CNS neuron population that can be selectively retrogradely labeled within a structure that can be subsequently grossly dissected out of the CNS. Although we have focused on its usefulness for purifying defined types of rodent neurons, in principle it should also work in larger mammals such as ferrets or primates.
We found that our CTB panning procedure seems to produce higher yields than comparable FACS purification procedures for the same cell population. FACS purification of mouse CSMNs produces yields of about 1000 CSMNs / brain at P4 (Arlotta et al., 2005; Ozdinler and Macklis, 2006) . Since mouse cortex has on average about 44% as many neurons as rat cortex (Herculano-Houzel and Lent, 2005; Herculano-Houzel et al., 2006) , if this same scaling applies to the CSMN population, then 1000 mouse CSMNs would correlate to about 2270 rat CSMNs. In comparison, the CTB panning purification yields about 9000 CSMNs / brain at P3, an increase of approximately four-fold over FACS yields. An earlier FACS purification protocol for P2 rat CSMNs reported yields of 4000 CSMNs per brain (Junger and Junger, 1998) ; again, a yield that is more than two-fold lower than that regularly attained with our CTB immunopanning purification. In addition, immunopanning is normally a gentler protocol than FACS-based purification, and therefore our protocol should in general yield neurons with improved initial viability, making them potentially more suitable for subsequent in vitro culturing experiments.
We did find that the efficiency of CTB immunopanning for RGCs was significantly less than the efficiency obtained by panning with the endogenous epitope Thy1.1. There are several possible explanations for this observation. First of all, it is very likely that only a subset of a CTB traced cell population becomes labeled with CTB, since retrograde labeling of axon tracts is usually incomplete, often labeling less than 25% of axons, and the extent of labeling varies widely with each injection (Bareyre et al., 2005) . The incomplete labeling of the CSMN population was apparent in our immunostained cortical slices (Fig. 2D) . The fact that several RGCs project to the lateral geniculate nucleus instead of the tracer-injected superior colliculus likely also contributes to this incomplete labeling. Furthermore, the level of surface expression of CTB may vary stochastically among the cell population. In any case, the presented procedure in principle greatly broadens the range of CNS neuron types that it is now possible to isolate for molecular and culture studies.
We also noticed a decrease in the amount of neurons that could be purified from retinal and cortical cell suspensions with increasing postnatal age. There may be several explanations for this observation that are not mutually exclusive. First, it is known that the absolute amounts of RGCs and CSMNs in the CNS decline during early postnatal development via programmed cell death (Jones et al, 1987 , Gorgels, 1990 , Terashima, 1995 , Spreafico et al, 1995 . Second, with increasing age, dendritic networks become more complex, which in combination with increases in the amount of connective tissue make it more difficult to generate a single cell suspension from both retina and cortex, thereby resulting in decreased yields. Third, increased sensitivity to excitotoxicity with increasing age might also contribute to more cell death during our dissociation procedure. These findings highlight the necessity to carefully select an appropriate age for retrograde labeling and subsequent tissue dissociation when using this procedure. In particular, motor neurons appear to be more difficult to isolate with maturation compared to most other neuron types.
cAMP, BDNF, and IGF1 support the survival of CSMNs
Our novel purification method has allowed us to directly examine the survival requirements of purified CSMNs. We found that increasing intracellular cAMP levels in the absence of peptide trophic factors could enhance CSMN viability. In the past, we and others have found that elevated cAMP levels alone strongly support the survival of some CNS neuron populations (SMNs and callosal projection neurons) (Catapano et al., 2001; Hanson et al., 1998) , but not RGCs or cortical neurons in general (Meyer-Franke et al., 1995) . Our observations indicate that increasing cAMP in CSMNs can support a low level of viability that is further enhanced by the addition of peptide trophic factors, similar to our previous observations with SMNs. We also confirmed that BDNF and IGF1 were significant survival factors for this population, agreeing with many previous studies (Giehl et al., 1998; Hammond et al., 1999; Lu et al., 2001; Ozdinler and Macklis, 2006; Schutte et al., 2000) , and further indicating that we had successfully purified layer V CSMNs. However, in several independent experiments we found that even BDNF, IGF1 and CPT-cAMP in combination could not support the long-term health of CSMNs in culture. These data indicated that CSMNs likely require additional trophic factors for their sustained survival.
Brain vascular cells support CSMN health
In analyzing the genomic expression profile of purified CSMNs, we discovered that they expressed several growth factor receptors that corresponded to ligands produced by brain vascular cells. Upon further investigation, we observed that medium conditioned by cultures of pure brain vascular endothelial cells could significantly enhance the survival of CSMNs in culture. In addition, the ECM greatly enhanced the morphological health of the CSMNs, with CSMNs cultured in the presence of ECM extending highly elongated and branched neurites. Significantly, this viability-promoting activity in ECM does not derive from BDNF or IGF1, neither of which was expressed by the brain vascular cells. Instead, we found that, among other factors, IGF2, CXCL12, and PTN were expressed by the brain vascular cells. IGF2 is a known neurotrophic factor (D'Costa et al., 1998; Dore et al., 1996; Motoike and Unsicker, 1999; Pu et al., 1999) , and its receptor can signal via a G-protein pathway (Hawkes et al., 2006; Hawkes and Kar, 2004 ). Yet IGF2 has not been considered before in the context of enhancing CSMN viability, although the closely related factor IGF1 is thought to promote CSMN survival. CXCL12 has been implicated in supporting embryonic neuronal survival and migration, and directing the projection of developing axons (including motor neuron axons), but a role in supporting CSMN survival has not been reported (Chalasani et al., 2003; Liapi et al., 2008; Lopez-Bendito et al., 2008; Stumm and Hollt, 2007) . PTN is also a known neurotrophic factor, including for SMNs (Mi et al., 2007; Mourlevat et al., 2005) , but it also has not been investigated for its effect on CSMNs. We examined the roles of all three of these EC-produced factors in supporting CSMN survival, and found that all could similarly promote CSMN viability and neurite extension, and that they were as effective as the previously characterized CSMN survival factors BDNF and IGF1. We also found that all three factors together with BDNF could equal the effectiveness of ECM, and that the combined factors in combination with ECM did not further enhance the ability of ECM to support CSMN health. Together, these data indicate that IGF2, CXCL12, and PTN represent novel, ECM-derived survival factors for CSMNs. We also observed that the expression of these survival factors (as well as the expression of TGFβ2 and Sema7A, the receptors for which are also expressed by CSMNs) was enriched or specific to the brain vasculature relative to other, non-neural tissues. These data indicate that, in addition to forming the blood-brain barrier, another role specific to the CNS endothelial cells and pericytes may be to supply trophic support to CNS neurons.
Vasculature is ubiquitous throughout the brain and present along the CST (Stanfield, 1992) , but a role for cerebral vasculature in providing neurotrophic support has not previously been considered. Yet there have been some prior observations indicating that this might be the case. Endothelial cells have been found to promote neural stem cell self-renewal and neuronal production in vitro (Shen et al., 2004) . In addition to a hypothesized role in controlling cell fate decisions, our data indicate that endothelial cells may also support the survival of neurons newly generated from neural stem cells. In addition, mixed ECs cultured by Leventhal et al. (1999) could support neurogenesis from neural precursors and, via the production of BDNF, some neuronal survival. However, these vascular cells were obtained from human umbilical cord, and therefore are distinct from the CNS-derived vascular cells we have used here. While we have shown that our cultures of pure brain ECs do not produce BDNF, they instead produce several additional factors that support the survival and morphological maturation of isolated CNS CSMNs. Furthermore, analysis of both our gene chip expression data and Allen Brain Atlas in situs indicates that receptors for EC-expressed trophic factors are not restricted to layer V, and are instead expressed more broadly throughout the CNS. Vascular endothelial growth factor (VEGF) and erythropoietin (EPO) are factors primarily associated with supporting the survival of vascular and hematopoietic cells, yet recent reports have also indicated potential neurotrophic roles for these factors, both in vitro and in mouse models of ALS (Koh et al., 2007; van der Kooij et al., 2008; Wang et al., 2007; Zachary, 2005) . Given the low levels of VEGF and EPO receptors on neurons (Cahoy et al., 2008) , it is possible that the in vivo neuroprotective effects reported for VEGF and EPO may derive primarily from promotion of vascular cell growth and therefore total production of vascular-derived neuronal survival factors such as IGF2, CXCL12, and PTN.
Understanding the molecular factors that control the survival of CSMNs contributes to our understanding of the development, plasticity, and function of the brain. In addition, our findings may lead to a better understanding of the vulnerabilities of CSMNs as observed in a variety of neurodevelopmental and neurodegenerative disorders; e.g. ALS and spinal cord injuries. Finally, our data indicate that the vascular cells of the brain should be considered as a previously overlooked potential source of trophic support for several populations of CNS neurons.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. A. Retrogradely transported CTB is cleaved from the surfaces of labeled cells during enzymatic dissociation, but internal stores of CTB bound to Retrobeads IX replace lost CTB during the post-dissociation recovery step and can then be selectively bound by immunopanning. Nnucleus; A-axon. B. CTB conjugated to fluorescent tracer Retrobeads injected into the superior collicular brachium is retrogradely transported to the retina. C. Fluorescent tracer is localized to the RGC layer in the retina 48 hours post-injection. Scale bar = 100 μm. RGC-RGC layer; IPL-inner plexiform layer; INL-inner nuclear layer; OPL-outer plexiform layer; ONL-outer nuclear layer; PE-pigmented epithelium. D. Phase-contrast image of CTB-panned RGCs in culture. Scale bar = 100 μm. E. Fluorescent image of the same field shows that purified RGCs A. CTB conjugated to fluorescent tracer Retrobeads is injected into the pyramidal decussation of the spinal cord and retrogradely transported to cortical layer V. B-C. Successfully retrogradely labeled dissected cortices (B) can easily be discerned from unsuccessful injections that fail to label layer V (C) using an inverted fluorescent microscope. Scale bar = 1mm. D-E. Immunohistochemistry shows that cells labeled with green fluorescent Retrobeads are layer V CSMNs. All retrogradely labeled (green) cells also label with CTIP2 (red), a nuclear marker for CSMNs (D). Blue DAPI costain shows that CTIP2 is specific for layer V cells (E). Scale bar = 100 μm. F. Immunocytochemistry of cultured purified cells shows that they are CSMNs. All purified cells labeled by neuronal marker MAP2 (green) coexpress CTIP2 (red). Scale bar = 100 μm. Comparison of expression levels of stereotypical neuronal, astrocyte, oligodendrocyte / oligodendrocyte precursor cell, and vascular cell (A) and CSMN-enriched (B) genes in purified CSMNs (black) and whole dissociated brain (grey) from P3 rats. Probe sets and expression values (arbitrary units) are shown in Table S2 . In cases where multiple probe sets are present for a single gene, the probe set with the highest expression was chosen. To fit the graph, the expression values for Syt1 and Snap25 were scaled down 3-fold for both samples. A. Percent purified P3 CSMNs surviving after 5 DIV in the various media listed. Neg-basal serum-free medium (see materials and methods); CPT-cAMP-CPT-cAMP added to basal medium; all remaining single / mutliple factors added in the presence of CPT-cAMP; All-CXCL12+IGF2+PTN+BDNF±IGF1 (no significant differences noted with / without IGF1 when the other four factors were present); ECM-fresh 10xECM added at plating and day 3 feeding. All data presented normalized to negative controls (Neg or CPT-cAMP) ±S.E.M.. ** -p < 0.0001 two-tailed Student's T-test; * -p < 0.001 multiple pairwise ANOVA post-hoc Student-Newman-Keuls test, all statistical differences found to control CPT-cAMP, no significant differences detected between the various +factor/ECM conditions. Neg n=20, CPT- Histograms showing percentages of purified P3 CSMNs alive at 5 DIV in indicated media, visualized by calcein-AM incubation, demonstrating < 50 μm, 50-400 μm, 400-800 μm, or > 800 μm total process outgrowth (G), or 0-1, 2-9, 10-50, or >50 total process branch points (H). In each condition > 20 randomly selected live cells were analyzed. Table 2 Receptors for several growth factors secreted by brain endothelial cells and pericytes are highly expressed by purified CSMNs Expression levels in arbitrary units derived from Affymetrix GCOS software. VC-expression level of indicated ligand in acutely purified postnatal vascular cells, from R. Daneman et al. (submitted) . 
